Sources inform “Globes” that AstraZeneca plc (NYSE; LSE; OMX: AZN) has teamed with Israeli real estate company Minrav Holdings Ltd. (tase:MNRV) to bid in the Office of the Chief Scientist’s biotechnology incubator tender. AstraZeneca will handle the consortium’s professional side, and Minrav will be responsible for financing.
The AstraZeneca-Minrav consortium is bidding against a consortium of OrbiMed Israel and the venture capital arms of Johnson & Johnson JNJ and Japan’s Takeda Pharmaceuticals Co. Ltd.
To read the full, original article click on this link: AstraZeneca teams with Minrav in biotech incubator tender – Financial and Business News – MENAFN
{iframe}http://www.menafn.com/029478b3-6b06-4c4a-940b-070c9acc561f/AstraZeneca-teams-with-Minrav-biotech-incubator-tender?src=main{/iframe}